Management of Symptomatic Uterine Fibroids in Pregnancy by Laparotomic Myomectomy: a Prospective Cohort Study
LPTM-UFs-P
LPTM-UFs-P
Sponsor study identifier
observational
28
1 country
1
Study Start
August 19, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
August 19, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
January 1, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The frequency of women presenting with a combination of uterine fibroids and pregnancy is in-creasing nowadays. Uterine fibroids in pregnancy are an unfavorable condition in themselves and being reactive to hormonal stimuli, tending to grow, can generate symptoms of different lev-els of severity. Obstetrics and gynecologists are increasingly faced with the problem of clarifying the management tactics of pregnant patients with symptomatic fibroids, who may see their preg-nancy put at risk by these masses.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 1, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 19, 2023
Actual (reported)August 19, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
August 19, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
August 24, 2023
Actual (reported)January 1, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
continuation of pregnancy
Pregnancy continuation after surgery.
5 months
Fetal outcome
5 months
Surgical removal of symptomatic uterine fibroids in pregnancy by laparotomic access
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
pregnant women with symptomatic uterine fibroids (UFs)
State-Funded Health Care Facility of Moscow Region (GBUZ MO MONIIAG)
Moscow, 101000, Russia
Andrea Etrusco, M.D.
University of Palermo
Antonio Simone Laganà, M.D. Ph.D.
University of Palermo
First Submitted
August 19, 2023
First Posted
August 24, 2023
Study Start
August 19, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
August 19, 2023
FRIEND: Fibroids and Unexplained Infertility Treatment With Epigallocatechin Gallate; A Natural CompounD in Green Tea
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
January 1, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
August 24, 2023
Record last verified: 2023-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: